Trilogy Capital’s Nuveen Dow 30SM Dynamic Overwrite Fund DIAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-846
Closed -$17K 239
2018
Q3
$17K Hold
846
﹤0.01% 280
2018
Q2
$16K Hold
846
﹤0.01% 269
2018
Q1
$15K Buy
+846
New +$15.5K ﹤0.01% 238

Other funds holding DIAX

Trilogy Capital's DIAX Position: Q4 2018 in Review

Trilogy Capital sold out of Nuveen Dow 30SM Dynamic Overwrite Fund (DIAX) in Q4 2018, closing a stake of 846 shares — an estimated $17K sold.

Trilogy Capital first reported a position in DIAX in Q1 2018 and held it in 3 quarters. The position peaked at $17K in Q3 2018. 84 funds tracked by Wall St. Rank hold DIAX as of Q4 2018.

  • Trilogy Capital reported no remaining Nuveen Dow 30SM Dynamic Overwrite Fund position as of Q4 2018 after selling out during the quarter.
  • Trilogy Capital sold 846 Nuveen Dow 30SM Dynamic Overwrite Fund shares in Q4 2018, an estimated $17K.
  • Trilogy Capital first reported a position in Nuveen Dow 30SM Dynamic Overwrite Fund in Q1 2018 and held it in 3 quarters.
  • Trilogy Capital's Nuveen Dow 30SM Dynamic Overwrite Fund position peaked at $17K in Q3 2018.
  • 84 funds tracked by Wall St. Rank held Nuveen Dow 30SM Dynamic Overwrite Fund as of Q4 2018.

Based on Trilogy Capital's 13F filing for Q4 2018, filed 15 Jan 2019.